VANCOUVER, BC, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (" Neovasc " or the " Company ") (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, announced today that the Company has entered into a binding agreement (the “ Arrangement Agreement ”) with Shockwave Medical, Inc. (“ Shockwave ”), whereby Shockwave has agreed to acquire all of the issued and outstanding common shares (the “ Common Shares...